Intervention Review

You have free access to this content

Interventions for the prevention of mycobacterium avium complex in adults and children with HIV

  1. Muhammed Mubashir B Uthman1,2,*,
  2. Olalekan A Uthman3,
  3. Ismail Yahaya4,5

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 30 APR 2013

Assessed as up-to-date: 11 JAN 2013

DOI: 10.1002/14651858.CD007191.pub2


How to Cite

Uthman MMB, Uthman OA, Yahaya I. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD007191. DOI: 10.1002/14651858.CD007191.pub2.

Author Information

  1. 1

    University of Ilorin, Department of Epidemiology & Community Health, Faculty of Clinical Sciences, College of Health Sciences, Ilorin, Kwara, Nigeria

  2. 2

    University of Ilorin Teaching Hospital (UITH), Ilorin, Nigeria

  3. 3

    Division of Health Sciences, Warwick Medical School, The University of Warwick, Warwick-Centre for Applied Health Research and Delivery (WCAHRD), Warwick, UK

  4. 4

    Mid-Sweden University, Department of Public Health, Sundsvall, Sweden

  5. 5

    Heart of England NHS Foundation Trust, Birmingham, UK

*Muhammed Mubashir B Uthman, uthmanmb@yahoo.com. mubashiruthman@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 30 APR 2013

SEARCH

[Figure 1]
Figure 1. Study flow diagram.
[Figure 2]
Figure 2. Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
[Figure 3]
Figure 3. Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
[Analysis 1.1]
Analysis 1.1. Comparison 1 Monotherapy versus no treatment or placebo, Outcome 1 Development of MAC disease.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Monotherapy versus no treatment or placebo, Outcome 2 All-cause mortality.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Monotherapy versus monotherapy, Outcome 1 Development of MAC disease.
[Analysis 2.2]
Analysis 2.2. Comparison 2 Monotherapy versus monotherapy, Outcome 2 All-cause mortality.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Combination therapy versus monotherapy, Outcome 1 Development of MAC disease.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Combination therapy versus monotherapy, Outcome 2 All-cause mortality.